Information  X 
Enter a valid email address

Tissue Regenix Grp PLC Ord0.5P (TRX)

Date Time Source Announcement
18 Feb 2019 7:00 am
RNS
Change of Adviser
06 Feb 2019 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
04 Feb 2019 7:00 am
RNS
Trading Update
17 Dec 2018 11:56 am
EQS
Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics
06 Dec 2018 7:00 am
RNS
Interim Management Change
13 Nov 2018 7:00 am
RNS
Pan European distribution agreement with Arthrex
29 Oct 2018 7:00 am
RNS
Gareth Jones commences position as CFO
14 Sep 2018 7:15 am
EQS
Tissue Regenix (TRX): Strategy delivering growth above expectations
03 Sep 2018 7:00 am
RNS
Unaudited Interim Results
02 Aug 2018 10:10 am
EQS
Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth
  7:00 am
RNS
Notice of Interim Results
04 Jul 2018 7:00 am
RNS
Appointment of CFO
25 Jun 2018 7:00 am
RNS
HTA License granted and UK distribution Agreement
21 Jun 2018 7:10 am
RNS
TRX BioSurgery wins GPO Supplier Horizon Award
18 Jun 2018 7:00 am
RNS
Issue of Equity
24 May 2018 12:12 pm
RNS
Result of AGM
02 May 2018 7:00 am
RNS
TRX BioSurgery GPO agreement with Premier, Inc.
27 Apr 2018 7:00 am
RNS
Posting of Annual Report and Notice of AGM
24 Apr 2018 7:00 am
RNS
DermaPure manufacturing at CellRight Facility
19 Apr 2018 3:29 pm
RNS
Holding(s) in Company
05 Apr 2018 7:15 am
EQS
Hardman & Co Research: Tissue Regenix (TRX): CellRight hits the right note
26 Mar 2018 7:00 am
RNS
Annual results for period ended 31 December 2017
16 Mar 2018 3:40 pm
RNS
Publication of Financial Results
08 Mar 2018 7:15 am
RNS
Hardman & Co: Full-year 2017 - what to look for
06 Mar 2018 7:00 am
RNS
Long term distribution agreement with Arthrex, Inc
26 Feb 2018 7:00 am
RNS
Launch of BioSurgery and new distributor agreement
  7:00 am
RNS
Notice of Results
02 Feb 2018 7:00 am
RNS
Issue of Equity
22 Dec 2017 9:30 am
RNS
Issue of Equity
01 Dec 2017 7:00 am
RNS
Directorate Change
  7:00 am
RNS
Issue of Equity
02 Nov 2017 7:00 am
RNS
Appointment of CEO
18 Oct 2017 7:00 am
RNS
Directorate Change
11 Oct 2017 7:15 am
RNS
Hardman Research: Dual revenue stream growth
28 Sep 2017 3:15 pm
RNS
Unaudited Interim Results
08 Sep 2017 7:00 am
RNS
Notice of Results
05 Sep 2017 3:52 pm
RNS
Notification Of Major Holdings
30 Aug 2017 5:15 pm
RNS
Issue of Equity
16 Aug 2017 12:22 pm
RNS
Holding(s) in Company
11 Aug 2017 3:45 pm
RNS
Holding(s) in Company
  3:37 pm
RNS
Holding(s) in Company
  3:37 pm
RNS
Holding(s) in Company
10 Aug 2017 4:30 pm
RNS
Holding(s) in Company
  2:45 pm
RNS
Holding(s) in Company
  1:10 pm
RNS
Hardman Research: CellRight transforming US growth
  10:10 am
RNS
Holding(s) in Company
09 Aug 2017 3:00 pm
RNS
Holding(s) in Company
  2:30 pm
RNS
Director/PDMR Shareholding
08 Aug 2017 1:41 pm
RNS
Results of General Meeting and Total Voting Rights
21 Jul 2017 6:00 pm
RNS
Circ re.CellRight Acquisition
  8:05 am
RNS
Successful fundraising of �40 million
20 Jul 2017 6:03 pm
RNS
Proposed Acquisition and Placing
30 Jun 2017 12:00 pm
RNS
Result of AGM
02 Jun 2017 7:00 am
RNS
Annual results for period ended 31 December 2016
31 May 2017 10:46 am
RNS
Potential Acquisition Update
19 May 2017 11:35 am
RNS
Potential Acquisition
03 Apr 2017 7:00 am
RNS
Issue of Equity
13 Mar 2017 7:10 am
RNS
Hardman Research: Addressing woundcare in the US
01 Mar 2017 7:00 am
RNS
Innovative Technology Contract Awarded
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t